Iwona Dobrucka is currently a senior research scientist at Beckman Institute and directs the Molecular Imaging Laboratory (MIL) in Biomedical Imaging Center (BIC). Prior to joining Beckman Institute in 2011, she did postdoctoral training in cancer biology at Yale University School of Medicine in the Department of Radiation Therapy, New Haven, Conn.

Research areas:

• Molecular imaging

• Molecular PET-CT

• Nanoparticle bioimaging probes

• Nanosensors

• Optical diagnostics for cancer

• SPECT-CT

Iwona Dobrucka's fields of professional interests include development of novel targeted microSPECT/PET-CT imaging strategies to stage cancer disease and assess tumor growth and metabolism in animal models of disease. In addition, her research is focused on studying interactions between traditional anti-cancer therapeutics and complementary alternative medicines (CAMs) used by cancer patients. Iwona Dobrucka’s expertise is in cancer cell biology and the pathophysiology of reactive oxygen species, including molecular imaging of tumor response to therapy and cardiotoxicity of anti-cancer drugs.